Clinical Trials Directory

Trials / Completed

CompletedNCT05629520

A Neurobiological Model of Anhedonia

Inflammatory, Behavioral and Neural Markers of Anhedonia in Major Depressive Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to better understand anhedonia in Major Depressive Disorder by investigating the reward-related neural and inflammatory correlates.

Detailed description

Background: Despite extensive research on the treatment of Major Depressive Disorder (MDD) relapse rates are as high as 80%. Of those, 30-40% fall into the severe spectrum called treatment resistant depression (TRD) as they fail to respond to at least two lines of antidepressant treatment interventions. TRD has been linked with anhedonia, the inability to experience pleasure or interest in usually enjoyable activities. The neurobiology of anhedonia is poorly understood with recent literature examining an inflammatory association and linking it to deficits in reward-related brain circuitry. The present study examines neurobiological correlates of anhedonia in MDD and TRD, specifically C-Reactive Protein (CRP), IL-6 and ventral striatal (VS) activity. The study also explores whether VS activity mediates the association between inflammation and anhedonia.

Conditions

Timeline

Start date
2020-02-19
Primary completion
2024-07-30
Completion
2024-07-30
First posted
2022-11-29
Last updated
2024-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05629520. Inclusion in this directory is not an endorsement.